Sort
40,608 grants matching “prostate cancer”
Imaging Mass Spectrometry Research Resource at Vanderbilt University
$1,847,655Richard M Caprioli · Vanderbilt University · P41 · FY2013 · GM
Mechanisms of Normal Tissue Toxicity From Irradiation
$1,846,567Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Targeting mechanisms of radiation resistance
$1,846,567Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
ACTIVATABLE CYTOKINES AS NOVEL AGENTS TO PROMOTE IMMUNE RESPONSES TO PROSTATE CANCER
$1,846,132University Of Rochester · · FY2017 · Department of the Army
Signaling and Progression in Prostate Cancer
$1,844,385Bryce M Paschal · University Of Virginia · P01 · FY2011 · CA
COTARGETING NSD1/2 PARALOGS IN AR-DRIVEN CASTRATION-RESISTANT PROSTATE CANCER
$1,844,306Regents Of The University Of Michigan · · FY2025 · Defense Health Agency
Improving Cancer Outcome--Adaptive Helical Tomotherapy
$1,844,141University Of Wisconsin Madison · P01 · FY2005 · CA
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
$1,843,767Jianghong Rao · Stanford University · U54 · FY2019 · CA
CANCER RESEARCH INFRASTRUCTURE DEVELOPMENT
$1,843,123Shafiq A Khan · Clark Atlanta University · G12 · FY2016 · MD
PROSTATE CANCER CLINICAL TRIALS GROUP: WAYNE STATE UNIVERSITY/KARMANOS CANCER INSTITUTE
$1,841,670Wayne State University · · FY2009 · Department of Defense
Center for Cancer Control in Persistent Poverty Areas (C3P2)
$1,841,031Maria Pisu · University Of Alabama At Birmingham · U54 · FY2024 · CA
Interrogating Epigenetic Changes in Cancer Genomes
$1,841,029Tim H.-M. Huang · University Of Texas Hlth Science Center · U54 · FY2013 · CA
HEROIC PROSTATE CANCER PRECISION HEALTH (PCAPH) AFRICA1K: POWERING PRECISION HEALTH TO IMPROVE PROSTATE CANCER OUTCOMES IN AFRICA
$1,839,317University Of Illinois · · FY2024 · Defense Health Agency
Improving Cancer Outcome--Adaptive Helical Tomotherapy
$1,839,019University Of Wisconsin Madison · P01 · FY2001 · CA
Consultation and Collaboration
$1,838,536Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Determinants of Liver Metastasis
$1,838,245Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2021 · CA
Development of Novel Cancer Therapeutics by Targeting Sphingolipid Signaling
$1,836,914Besim Ogretmen · Medical University Of South Carolina · P01 · FY2018 · CA
THERAPY OF ADVANCED PROSTATE CANCER WITH A NOVEL CELL THERAPY
$1,836,611Virginia Commonwealth University · · FY2025 · Defense Health Agency
SHARK ANTIBODY RADIOPHARMACEUTICALS FOR THE TREATMENT OF PROSTATE CANCER
$1,836,030University Of Wisconsin System · · FY2025 · Defense Health Agency
High-throughput Clinical Hyperpolarized 13C MRI
$1,835,840Leo Lee Tsai · Massachusetts General Hospital · S10 · FY2025 · OD
Signaling and Progression in Prostate Cancer
$1,834,557University Of Virginia Charlottesville · P01 · FY2005 · CA
Viral transmission and pathogenesis in human tissues
$1,833,748Leonid B. Margolis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Washington University Molecular Imaging Center
$1,832,986Washington University · P50 · FY2003 · CA
Consultation and Collaboration
$1,831,605Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Targeting mechanisms of radiation resistance
$1,829,924Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA